Scott SM, Brown M, Come SE (2011). “Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer”. Expert Opin Drug Saf10 (5): 819–26. doi:10.1517/14740338.2011.595560. PMID21699443.
Croxtall JD, McKeage K (2011). “Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women”. Drugs71 (3): 363–80. doi:10.2165/11204810-000000000-00000. PMID21319872.
Valachis A, Mauri D, Polyzos NP, Mavroudis D, Georgoulias V, Casazza G (2010). “Fulvestrant in the treatment of advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials”. Crit. Rev. Oncol. Hematol.73 (3): 220–7. doi:10.1016/j.critrevonc.2009.03.006. PMID19369092.
Flemming J, Madarnas Y, Franek JA (2009). “Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review”. Breast Cancer Res. Treat.115 (2): 255–68. doi:10.1007/s10549-008-0137-8. PMID18683044.
nih.gov
pubmed.ncbi.nlm.nih.gov
Scott SM, Brown M, Come SE (2011). “Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer”. Expert Opin Drug Saf10 (5): 819–26. doi:10.1517/14740338.2011.595560. PMID21699443.
Croxtall JD, McKeage K (2011). “Fulvestrant: a review of its use in the management of hormone receptor-positive metastatic breast cancer in postmenopausal women”. Drugs71 (3): 363–80. doi:10.2165/11204810-000000000-00000. PMID21319872.
Valachis A, Mauri D, Polyzos NP, Mavroudis D, Georgoulias V, Casazza G (2010). “Fulvestrant in the treatment of advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials”. Crit. Rev. Oncol. Hematol.73 (3): 220–7. doi:10.1016/j.critrevonc.2009.03.006. PMID19369092.
Flemming J, Madarnas Y, Franek JA (2009). “Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review”. Breast Cancer Res. Treat.115 (2): 255–68. doi:10.1007/s10549-008-0137-8. PMID18683044.